{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:54:55Z","timestamp":1781740495085,"version":"3.54.5"},"reference-count":247,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrep.2026.102518","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:14:02Z","timestamp":1773130442000},"page":"102518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Persistent prostaglandin E2 upregulation and hormonal multi-resistance: A hypothesis for long COVID"],"prefix":"10.1016","volume":"46","author":[{"given":"Vjera","family":"Ramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert A.","family":"van Montfrans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102518_bib1","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","article-title":"Mechanisms of long COVID and the path toward therapeutics","volume":"187","author":"Peluso","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2026.102518_bib2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nn.3159","article-title":"Neural circuitry engaged by prostaglandins during the sickness syndrome","volume":"15","author":"Saper","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102518_bib3","first-page":"109","article-title":"Roles of inflammation-related molecules in emotional changes induced by repeated stress]","volume":"34","author":"Kitaoka","year":"2014","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi."},{"key":"10.1016\/j.bbrep.2026.102518_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41586-023-05796-0","article-title":"An airway-to-brain sensory pathway mediates influenza-induced sickness","volume":"615","author":"Bin","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2026.102518_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255335","article-title":"Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease","volume":"16","author":"Ricke-Hoch","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102518_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202000198","article-title":"Why does COVID-19 pathology have several clinical forms?","volume":"42","author":"Aliabadi","year":"2020","journal-title":"Bioessays"},{"key":"10.1016\/j.bbrep.2026.102518_bib7","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1093\/cid\/ciab147","article-title":"Plasma metabolomic profiling of patients recovered from coronavirus disease 2019 (COVID-19) with pulmonary sequelae 3 months after discharge","volume":"73","author":"Xu","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrep.2026.102518_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0316373","article-title":"Increased galanin-galanin receptor 1 signaling, inflammation, and insulin resistance are associated with affective symptoms and chronic fatigue syndrome due to long COVID","volume":"20","author":"Al Masoodi","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102518_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MNH.0000000000000750","article-title":"Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis","volume":"31","author":"Chiang","year":"2022","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.bbrep.2026.102518_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1440","article-title":"Deep phenotyping of the lipidomic response in COVID-19 and non-COVID-19 sepsis","volume":"13","author":"Meng","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41591-022-02116-3","article-title":"Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes","volume":"29","author":"Zhang","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine."},{"key":"10.1016\/j.bbrep.2026.102518_bib13","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1007\/s12035-024-04421-z","article-title":"A disease hidden in plain sight: pathways and mechanisms of neurological complications of post-acute sequelae of COVID-19 (NC-PASC)","volume":"62","author":"Saxena","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"Suppl 1","key":"10.1016\/j.bbrep.2026.102518_bib14","first-page":"S182","article-title":"Prostaglandins, bioassay and inflammation","volume":"147","author":"Flower","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1999.79.4.1193","article-title":"Prostanoid receptors: structures, properties, and functions","volume":"79","author":"Narumiya","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrep.2026.102518_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","article-title":"Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases","volume":"119","author":"Park","year":"2006","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF02857948","article-title":"Prostaglandins and related substances in plants","volume":"63","author":"Groenewald","year":"1997","journal-title":"Bot. Rev."},{"key":"10.1016\/j.bbrep.2026.102518_bib18","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/ismej.2017.27","article-title":"Animal-like prostaglandins in marine microalgae","volume":"11","author":"Di Dato","year":"2017","journal-title":"ISME J."},{"key":"10.1016\/j.bbrep.2026.102518_bib19","doi-asserted-by":"crossref","first-page":"15719","DOI":"10.1074\/jbc.274.22.15719","article-title":"Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope","volume":"274","author":"Bhattacharya","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102518_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1042\/BST0321078","article-title":"Study of prostaglandin receptors in mitochondria on apoptosis of human lung carcinoma cell line A549","volume":"32","author":"Fang","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbrep.2026.102518_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12079-020-00585-0","article-title":"A review of prostanoid receptors: expression, characterization, regulation, and mechanism of action","volume":"15","author":"Biringer","year":"2021","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.bbrep.2026.102518_bib22","article-title":"Roles of EP receptors in the regulation of fluid balance and blood pressure","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrep.2026.102518_bib23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41556-021-00708-8","article-title":"E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis","volume":"23","author":"Patankar","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102518_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110167","article-title":"Flavors of GPCR signaling bias","volume":"261","author":"Seyedabadi","year":"2024","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/intimm\/dxz021","article-title":"Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases","volume":"31","author":"Tsuge","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.05.011","article-title":"Prostaglandin E2 induces apoptosis in cultured rat microglia","volume":"1568","author":"Nagano","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/2058739218796386","article-title":"PGE2 stimulates COX-2 expression via EP2\/4 receptors and acts in synergy with IL-1\u03b2 in human follicular dendritic cell-like cells","volume":"16","author":"Nam","year":"2018","journal-title":"Eur. J. Inflamm."},{"key":"10.1016\/j.bbrep.2026.102518_bib28","doi-asserted-by":"crossref","first-page":"17214","DOI":"10.1074\/jbc.M111.304220","article-title":"Prostaglandin EP1 receptor down-regulates expression of Cyclooxygenase-2 by facilitating its proteasomal degradation","volume":"287","author":"Haddad","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102518_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091018","article-title":"Upregulation of prostaglandin receptor EP1 expression involves its association with cyclooxygenase-2","volume":"9","author":"Sood","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102518_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4049\/jimmunol.2200079","article-title":"Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity","volume":"209","author":"P\u00e9rez","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1470193","article-title":"Proteomic and metabolomic profiling of plasma uncovers immune responses in patients with long COVID-19","volume":"15","author":"Wei","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib32","first-page":"620","article-title":"Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells","volume":"86","author":"Zeng","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.bbrep.2026.102518_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1189\/jlb.1203627","article-title":"Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production","volume":"76","author":"Akaogi","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrep.2026.102518_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12974-016-0780-7","article-title":"Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide","volume":"14","author":"Bonfill-Teixidor","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbrep.2026.102518_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.febslet.2004.06.089","article-title":"Human prostaglandin EP3 receptor isoforms show different agonist-induced internalization patterns","volume":"572","author":"Bilson","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2026.102518_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010468","article-title":"D-dimer and CoV-2 spike-immune complexes contribute to the production of PGE2 and proinflammatory cytokines in monocytes","volume":"18","author":"Park","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrep.2026.102518_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2213","article-title":"Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients","volume":"31","author":"Rahman","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bbrep.2026.102518_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847809","article-title":"Plasma angiotensin II is increased in critical coronavirus disease 2019","volume":"9","author":"Camargo","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib39","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.30.1_supplement.1198.6","article-title":"Angiotensin II induces prostaglandin E2 production and oxidative stress in the renal cortex","volume":"30","author":"Alanazi","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrep.2026.102518_bib40","doi-asserted-by":"crossref","first-page":"F1038","DOI":"10.1152\/ajprenal.00194.2017","article-title":"PGE(2) upregulates renin through E-prostanoid receptor 1 via PKC\/cAMP\/CREB pathway in M-1 cells","volume":"313","author":"Gonzalez","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/sj.bjp.0702057","article-title":"Prostanoid receptors of the EP3 subtype mediate inhibition of evoked [3H]acetylcholine release from isolated human bronchi","volume":"125","author":"Reinheimer","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib42","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/sj.bjp.0705648","article-title":"E-ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype","volume":"141","author":"Clarke","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(88)91468-0","article-title":"Acetylcholine dramatically increases prostanoid synthesis in piglet parietal cortex","volume":"439","author":"Busija","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-5793(80)80928-8","article-title":"Acetylcholine promotes the synthesis of prostaglandin E in mouse pancreas","volume":"117","author":"Banschbach","year":"1980","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.bbrep.2026.102518_bib45","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1074\/jbc.274.3.1776","article-title":"Cytokine-induced prostaglandin E2 synthesis and Cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro","volume":"274","author":"Hughes","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102518_bib46","doi-asserted-by":"crossref","first-page":"25693","DOI":"10.1074\/jbc.272.41.25693","article-title":"Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2","volume":"272","author":"Williams","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102518_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib48","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s004240100572","article-title":"Cytokines and cytokine inducers stimulate prostaglandin E2 entry into the brain","volume":"442","author":"Davidson","year":"2001","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.bbrep.2026.102518_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153751","article-title":"Prostaglandin E2 exerts multiple regulatory actions on human Obese adipose tissue remodeling, inflammation, adaptive thermogenesis and lipolysis","volume":"11","author":"Garc\u00eda-Alonso","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102518_bib50","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","article-title":"The immunology of long COVID","volume":"23","author":"Altmann","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/26233","article-title":"Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3","volume":"395","author":"Ushikubi","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2026.102518_bib52","doi-asserted-by":"crossref","first-page":"H1559","DOI":"10.1152\/ajpheart.00262.2011","article-title":"EP3 receptors mediate PGE2-induced hypothalamic paraventricular nucleus excitation and sympathetic activation","volume":"301","author":"Zhang","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib53","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1476-5381.1995.tb14985.x","article-title":"Elevation of plasma noradrenaline levels in urethane-anaesthetized rats by activation of central prostanoid EP3 receptors","volume":"115","author":"Yokotani","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib54","article-title":"Cardiovascular and autonomic dysfunction in long-COVID syndrome and the potential role of non-invasive therapeutic strategies on cardiovascular outcomes","volume":"9","author":"Allendes","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112193","article-title":"Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective","volume":"143","author":"Al-Kuraishy","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrep.2026.102518_bib56","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2023.8823","article-title":"Development of a definition of postacute sequelae of SARS-CoV-2 infection","volume":"329","author":"Thaweethai","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.bbrep.2026.102518_bib57","first-page":"F318","article-title":"PGE2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation","volume":"259","author":"H\u00e9bert","year":"1990","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib58","first-page":"F499","article-title":"Prostaglandin E2 and cyclic AMP response to vasopressin in renal medullary tubular cells","volume":"251","author":"Wuthrich","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0952-3278(98)90156-9","article-title":"Arginine vasopressin stimulates phospholipid methylation in cultured rat mesangial cells: possible role for PGE2 production","volume":"58","author":"Nishida","year":"1998","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbrep.2026.102518_bib60","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1172\/JCI110931","article-title":"Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects of angiotensin II and arginine vasopressin","volume":"71","author":"Scharschmidt","year":"1983","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2026.102518_bib61","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0006-2952(02)01020-1","article-title":"Dopamine D2 receptor-induced COX-2-mediated production of prostaglandin E2 in D2-transfected Chinese hamster ovary cells without simultaneous administration of a Ca2+-mobilizing agent","volume":"63","author":"Hellstrand","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib62","doi-asserted-by":"crossref","first-page":"F647","DOI":"10.1152\/ajprenal.1991.261.4.F647","article-title":"Prostaglandin E2 production in rat IMCD cells. I. Stimulation by dopamine","volume":"261","author":"Huo","year":"1991","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib63","doi-asserted-by":"crossref","first-page":"F450","DOI":"10.1152\/ajprenal.00234.2005","article-title":"Fibroblast growth factor-23 increases mouse PGE2 production in vivo and in vitro","volume":"290","author":"Syal","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00925983","article-title":"Fibroblast growth factor increases TNF alpha-mediated prostaglandin E2 production and TNF alpha receptor expression in human fibroblasts","volume":"120","author":"Candela","year":"1993","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbrep.2026.102518_bib65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0952-3278(90)90049-Q","article-title":"Interferon gamma stimulates prostaglandin E2 production by mouse Kupffer cells","volume":"40","author":"Kawada","year":"1990","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.bbrep.2026.102518_bib66","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.4142\/jvs.2021.22.e16","article-title":"Feline adipose tissue-derived mesenchymal stem cells pretreated with IFN-\u03b3 enhance immunomodulatory effects through the PGE2 pathway","volume":"22","author":"Park","year":"2021","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib67","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00296-008-0564-1","article-title":"Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells","volume":"28","author":"Seidel","year":"2008","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bbrep.2026.102518_bib68","doi-asserted-by":"crossref","first-page":"F844","DOI":"10.1152\/ajprenal.1986.251.5.F844","article-title":"Effect of serotonin on prostaglandin synthesis in rat cultured mesangial cells","volume":"251","author":"Knauss","year":"1986","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib69","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1210\/en.2006-1315","article-title":"Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice","volume":"148","author":"Aoyagi","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrep.2026.102518_bib70","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1152\/japplphysiol.01007.2001","article-title":"Invited review: molecular adaptations in mammalian hibernators: unique adaptations or generalized responses?","volume":"92","author":"Van Breukelen","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110202","article-title":"The bidirectional association between diabetes and long-COVID-19 \u2013 a systematic review","volume":"195","author":"Harding","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrep.2026.102518_bib72","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1096\/fj.201500127","article-title":"Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance","volume":"30","author":"Chan","year":"2016","journal-title":"Faseb j"},{"key":"10.1016\/j.bbrep.2026.102518_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108265","article-title":"Prostaglandin E2-EP4 axis promotes lipolysis and fibrosis in adipose tissue leading to ectopic fat deposition and insulin resistance","volume":"33","author":"Inazumi","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrep.2026.102518_bib74","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.23064","article-title":"Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes","volume":"50","author":"Henkel","year":"2009","journal-title":"Hepatol"},{"key":"10.1016\/j.bbrep.2026.102518_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136304","article-title":"The prostaglandin E2 receptor EP4 regulates obesity-related inflammation and insulin sensitivity","volume":"10","author":"Yasui","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102518_bib76","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1073\/pnas.0611209104","article-title":"Night eating and obesity in the EP3R-deficient mouse","volume":"104","author":"Sanchez-Alavez","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.bbrep.2026.102518_bib77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0090-6980(01)00136-8","article-title":"Obesity is induced in mice heterozygous for cyclooxygenase-2","volume":"65","author":"Fain","year":"2001","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.bbrep.2026.102518_bib78","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0002-9378(16)32331-6","article-title":"Prostaglandin E2 attenuates the pressor response to angiotensin II in pregnant subjects but not in nonpregnant subjects","volume":"142","author":"Broughton Pipkin","year":"1982","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bbrep.2026.102518_bib79","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI90678","article-title":"Prostaglandin-mediated inhibition of serotonin signaling controls the affective component of inflammatory pain","volume":"127","author":"Singh","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2026.102518_bib80","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1460-9568.2009.07021.x","article-title":"Prostaglandin E receptor EP1 enhances GABA-mediated inhibition of dopaminergic neurons in the substantia nigra pars compacta and regulates dopamine level in the dorsal striatum","volume":"30","author":"Tanaka","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102518_bib81","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00467-006-0126-2","article-title":"Role of prostaglandins in the pathogenesis of X-linked hypophosphatemia","volume":"21","author":"Baum","year":"2006","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.bbrep.2026.102518_bib82","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/eji.200838170","article-title":"Mutual antagonistic relationship between prostaglandin E(2) and IFN-gamma: implications for rheumatoid arthritis","volume":"38","author":"Mathieu","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib83","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/cts.12953","article-title":"SARS-CoV-2 infection as a trigger of autoimmune response","volume":"14","author":"Sacchi","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib84","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s43856-024-00477-z","article-title":"Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity","volume":"4","author":"Geanes","year":"2024","journal-title":"Commun. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib85","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2025.02.005","article-title":"Autoimmunity in long COVID","volume":"155","author":"Talwar","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.981532","article-title":"Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity","volume":"13","author":"Sotzny","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11102668","article-title":"Animals experimentally infected with SARS-CoV-2 generate functional autoantibodies against G-Protein-Coupled receptors","volume":"11","author":"Wallukat","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrep.2026.102518_bib88","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.4049\/jimmunol.147.8.2500","article-title":"Antigen-specific IGG2A production in response to prostaglandin E2, immune complexes, and IFN-gamma","volume":"147","author":"Stein","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib89","doi-asserted-by":"crossref","first-page":"10978","DOI":"10.1073\/pnas.93.20.10978","article-title":"Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells","volume":"93","author":"Fedyk","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.bbrep.2026.102518_bib90","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/IAI.68.3.1563-1568.2000","article-title":"Regulation of Immunoglobulin G2 production by prostaglandin E2 and platelet-activating factor","volume":"68","author":"Ishihara","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrep.2026.102518_bib91","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.149.9.2984","article-title":"Prostaglandin E2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis","volume":"149","author":"Roper","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib93","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2741\/4698","article-title":"Antibodies against GPCR","volume":"23","author":"Meyer","year":"2018","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.bbrep.2026.102518_bib94","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/molpharm.120.000170","article-title":"Phosphoproteomics-Based characterization of prostaglandin E2 signaling in T cells","volume":"99","author":"Lone","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018500","article-title":"Prostaglandin E2 regulates AMPA receptor phosphorylation and promotes membrane insertion in preoptic area neurons and glia during sexual differentiation","volume":"6","author":"Lenz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102518_bib96","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3233\/JAD-181066","article-title":"Cyclooxygenase-2 is essential for mediating the effects of calcium ions on stimulating phosphorylation of tau at the sites of ser 396 and ser 404","volume":"68","author":"Cao","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbrep.2026.102518_bib97","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3892\/ijo.2013.1859","article-title":"Prostaglandin E2 receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells","volume":"42","author":"Bai","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrep.2026.102518_bib98","doi-asserted-by":"crossref","first-page":"13629","DOI":"10.1016\/S0021-9258(18)89786-1","article-title":"Phosphorylation of RNA polymerase I augments its interaction with autoantibodies of systemic lupus erythematosus patients","volume":"259","author":"Stetler","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102518_bib99","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0167-4889(87)90124-8","article-title":"Multiple phosphorylation of human SS-B\/LA autoantigen and its effect on poly(U) and autoantibody binding","volume":"928","author":"Pfeifle","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrep.2026.102518_bib100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/sj.bjp.0705648","article-title":"E-Ring 8-isoprostanes inhibit ACh release from parasympathetic nerves innervating guinea-pig trachea through agonism of prostanoid receptors of the EP3-subtype","volume":"141","author":"Clarke","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib101","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2337\/db12-0769","article-title":"Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion","volume":"62","author":"Kimple","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrep.2026.102518_bib102","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1471-4159.1998.71020646.x","article-title":"Inhibition of dopamine release by prostaglandin EP3 receptor via pertussis toxin-sensitive and -insensitive pathways in PC12 cells","volume":"71","author":"Nakamura","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrep.2026.102518_bib103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00210-009-0478-9","article-title":"Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266","volume":"381","author":"G\u00fcnther","year":"2010","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bbrep.2026.102518_bib104","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj20030312","article-title":"Mechanisms of cross-talk between G-protein-coupled receptors resulting in enhanced release of intracellular Ca2+","volume":"374","author":"Werry","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrep.2026.102518_bib105","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41422-023-00808-0","article-title":"Structural genomics of the human dopamine receptor system","volume":"33","author":"Xu","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib106","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1038\/s41467-024-52585-y","article-title":"Structural basis of ligand recognition and activation of the histamine receptor family","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2026.102518_bib107","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5483\/BMBRep.2023-0147","article-title":"Structural studies of serotonin receptor family","volume":"56","author":"Parajulee","year":"2023","journal-title":"BMB Rep."},{"key":"10.1016\/j.bbrep.2026.102518_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052919","article-title":"Real-Time determination of intracellular cAMP reveals functional coupling of G(s) protein to the Melatonin MT(1) receptor","volume":"25","author":"Tse","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib109","article-title":"The \u03b2(3)-Adrenergic receptor: structure, physiopathology of disease, and emerging therapeutic potential","volume":"2024","author":"Dongdem","year":"2024","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib110","doi-asserted-by":"crossref","first-page":"C731","DOI":"10.1152\/ajpcell.00210.2022","article-title":"G protein-coupled receptor signaling: transducers and effectors","volume":"323","author":"Jiang","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib111","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.31.1_supplement.675.6","article-title":"Prostaglandin E2 (PGE2) Levels as a Predictor of type 2 diabetes control in human subjects: a cross-sectional view of initial cohort study data","volume":"31","author":"Fenske","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrep.2026.102518_bib112","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1089\/jir.2014.0194","article-title":"Obesity-associated inflammatory cytokines and prostaglandin E2 stimulate glucose transporter mRNA expression and glucose uptake in primary human adipose stromal cells","volume":"35","author":"Docanto","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib113","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","article-title":"Phosphorylation of IRS proteins, insulin action, and insulin resistance","volume":"296","author":"Boura-Halfon","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrep.2026.102518_bib114","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cmet.2025.01.001","article-title":"A cellular and molecular basis of leptin resistance","volume":"37","author":"Tan","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbrep.2026.102518_bib115","doi-asserted-by":"crossref","first-page":"C639","DOI":"10.1152\/ajpcell.00417.2014","article-title":"Prostaglandin E2 activates the mTORC1 pathway through an EP4\/cAMP\/PKA- and EP1\/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1","volume":"309","author":"Chang","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib116","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1016\/j.molimm.2008.01.025","article-title":"Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of Colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation","volume":"45","author":"Sun","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib117","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cardiores.2006.09.016","article-title":"Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: a role in cardiac hypertrophy","volume":"73","author":"Frias","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib118","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.3324\/haematol.2018.202374","article-title":"Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression","volume":"104","author":"Todaro","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.bbrep.2026.102518_bib119","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12986-021-00569-w","article-title":"STAT3 phosphorylation in central leptin resistance","volume":"18","author":"Liu","year":"2021","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.bbrep.2026.102518_bib120","first-page":"89","article-title":"The role of SOCS-3 protein in leptin resistance and obesity","volume":"40","author":"Lubis","year":"2008","journal-title":"Acta Med. Indones."},{"key":"10.1016\/j.bbrep.2026.102518_bib121","article-title":"Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3)","volume":"7","author":"Yang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2026.102518_bib122","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/cei\/uxab001","article-title":"Leptin-reactive antibodies are distinctly correlated with body composition parameters and metabolic risk indexes in children and adolescents","volume":"208","author":"V\u00e1zquez-Sol\u00f3rzano","year":"2022","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib123","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/jmcb\/mjw035","article-title":"Prostaglandin E2 receptor EP3 regulates both adipogenesis and lipolysis in mouse white adipose tissue","volume":"8","author":"Xu","year":"2016","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.bbrep.2026.102518_bib124","first-page":"1577","article-title":"Feedback-inhibition of glucagon-stimulated glycogenolysis in Hepatocyte\/Kupffer cell cocultures by glucagon-elicited prostaglandin production in kupffer cells","volume":"22","author":"Hespeling","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrep.2026.102518_bib125","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00125-016-3916-5","article-title":"PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes","volume":"59","author":"Hassouneh","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrep.2026.102518_bib126","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021110439","article-title":"PGE(2) -EP3 axis promotes brown adipose tissue formation through stabilization of WTAP RNA methyltransferase","volume":"41","author":"Tao","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrep.2026.102518_bib127","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00061.2023","article-title":"The prostaglandin E(2) EP3 receptor has disparate effects on islet insulin secretion and content in \u03b2-cells in a high-fat diet-induced mouse model of obesity","volume":"326","author":"Neuman","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrep.2026.102518_bib128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-2999(99)00085-0","article-title":"Leptin stimulates prostaglandin E2 and F2alpha, but not nitric oxide production in neonatal rat hypothalamus","volume":"369","author":"Brunetti","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib129","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1681\/ASN.V9112005","article-title":"High glucose increases prostaglandin E2 synthesis in human peritoneal mesothelial cells: role of hyperosmolarity","volume":"9","author":"Sitter","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrep.2026.102518_bib130","first-page":"F802","article-title":"vasopressin-stimulated cAMP, and PGE2 synthesis in rat collecting tubule cells","volume":"250","author":"Sato","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib131","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbadis.2008.09.005","article-title":"Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity","volume":"1792","author":"Morrison","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.bbrep.2026.102518_bib132","doi-asserted-by":"crossref","DOI":"10.1007\/s11897-021-00527-w","article-title":"Clinical phenotypes in patients with type 2 diabetes mellitus: characteristics, cardiovascular outcomes and treatment strategies","volume":"18","author":"Gouda","year":"2021","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.bbrep.2026.102518_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12030810","article-title":"Two distinct groups are shown to be at risk of diabetes by means of a cluster analysis of four variables","volume":"12","author":"Ito","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib134","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/en.2015-1693","article-title":"The PGE2 EP3 receptor regulates diet-induced adiposity in Male mice","volume":"157","author":"Ceddia","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrep.2026.102518_bib135","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00538.2019","article-title":"The deleterious role of the prostaglandin E 2 EP3 receptor in angiotensin II hypertension","volume":"318","author":"Bryson","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib136","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003291","article-title":"Prostaglandin E2 reduces cardiac contractility via EP3 receptor","volume":"9","author":"Gu","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.bbrep.2026.102518_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121277","article-title":"Deleterious effects of cardiomyocyte-specific prostaglandin E2 EP3 receptor overexpression on cardiac function after myocardial infarction","volume":"313","author":"Maxwell","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib138","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.kint.2022.08.019","article-title":"E-prostanoid 3 receptor deficiency on myeloid cells protects against ischemic acute kidney injury via breaking the auto-amplification loop of necroinflammation","volume":"103","author":"Leng","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbrep.2026.102518_bib140","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1097\/00001756-200007140-00014","article-title":"Prostaglandin E (EP) receptor subtypes and sleep: promotion by EP4 and inhibition by EP1\/EP2","volume":"11","author":"Yoshida","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbrep.2026.102518_bib141","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1172\/JCI25840","article-title":"Airway smooth muscle prostaglandin-EP1 receptors directly modulate beta2-adrenergic receptors within a unique heterodimeric complex","volume":"116","author":"McGraw","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2026.102518_bib142","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1254\/jphs.12R09CP","article-title":"Roles of dopamine and inflammation-related molecules in behavioral alterations caused by repeated stress","volume":"120","author":"Furuyashiki","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib143","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/cells14020116","article-title":"Targeting EP2 receptor improves muscle and bone health in Dystrophin\u2212\/\u2212\/Utrophin\u2212\/\u2212 double-knockout mice","volume":"14","author":"Gao","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bbrep.2026.102518_bib144","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1038\/s41598-017-09528-z","article-title":"Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype","volume":"7","author":"Kang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102518_bib145","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6101838","article-title":"Generation of cellular reactive oxygen species by activation of the EP2 receptor contributes to prostaglandin E2-Induced cytotoxicity in Motor neuron-like NSC-34 cells","author":"Kosuge","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bbrep.2026.102518_bib146","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.2011.07363.x","article-title":"The cyclooxygenase-2 pathway via the PGE2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination","volume":"121","author":"Palumbo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrep.2026.102518_bib147","doi-asserted-by":"crossref","first-page":"G1097","DOI":"10.1152\/ajpgi.00280.2010","article-title":"Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity","volume":"299","author":"Lejeune","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib148","doi-asserted-by":"crossref","first-page":"L266","DOI":"10.1152\/ajplung.00248.2011","article-title":"Prostaglandin E2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells","volume":"302","author":"Aso","year":"2011","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib149","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pupt.2017.11.001","article-title":"Activating prostaglandin E2 receptor subtype EP4 increases secreted mucin from airway goblet cells","volume":"48","author":"Akaba","year":"2018","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.bbrep.2026.102518_bib150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11606-022-07908-4","article-title":"Symptom clusters seen in adult COVID-19 recovery clinic care seekers","volume":"38","author":"Danesh","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib151","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.4049\/jimmunol.0900129","article-title":"E-prostanoid 3 receptor deletion improves pulmonary host defense and protects mice from death in severe Streptococcus pneumoniae infection","volume":"183","author":"Aronoff","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib152","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1164\/rccm.200903-0388OC","article-title":"Prostaglandin E2 mediates cough via the EP3 receptor: implications for future disease therapy","volume":"180","author":"Maher","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1221961","article-title":"Divergent adaptive immune responses define two types of long COVID","volume":"14","author":"Kervevan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib154","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2567.2006.02376.x","article-title":"E prostanoid 2 (EP2)\/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2","volume":"118","author":"Okano","year":"2006","journal-title":"Immunology"},{"issue":"Suppl 3","key":"10.1016\/j.bbrep.2026.102518_bib155","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1093\/infdis\/jiu232","article-title":"Sex differences in pediatric infectious diseases","volume":"209","author":"Muenchhoff","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbrep.2026.102518_bib156","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7827-10-3","article-title":"Prostaglandin receptors EP and FP are regulated by estradiol and progesterone in the uterus of ovariectomized rats","volume":"10","author":"Blesson","year":"2012","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.bbrep.2026.102518_bib157","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jama.2024.12747","article-title":"Characterizing long COVID in children and adolescents","volume":"332","author":"Gross","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.bbrep.2026.102518_bib158","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S2352-4642(22)00154-7","article-title":"Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study","volume":"6","author":"Kikkenborg Berg","year":"2022","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.bbrep.2026.102518_bib170","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1152\/japplphysiol.00396.2015","article-title":"Prostaglandin E2\/cyclooxygenase pathway in human skeletal muscle: influence of muscle fiber type and age","volume":"120","author":"Liu","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib171","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1038\/s41467-022-34593-y","article-title":"Age-induced prostaglandin E2 impairs mitochondrial fitness and increases mortality to influenza infection","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2026.102518_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1295991","article-title":"The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function","volume":"16","author":"Rashid","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102518_bib173","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE(2) inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2026.102518_bib174","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1074\/jbc.M506846200","article-title":"Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages","volume":"281","author":"Pavlovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102518_bib139","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yjmcc.2019.11.135","article-title":"The role of E-type prostaglandin receptor EP3 in acute renal injury induced by ischemia-reperfusion","volume":"140","author":"Jing","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib175","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.2174\/1381612824666180629111227","article-title":"Roles of cyclooxygenase, prostaglandin E2 and EP receptors in mucosal protection and ulcer healing in the gastrointestinal tract","volume":"24","author":"Takeuchi","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbrep.2026.102518_bib176","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1096\/fj.02-0501fje","article-title":"Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor","volume":"17","author":"Carrillo-Vico","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrep.2026.102518_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813816","article-title":"Anti-inflammatory effects of peripheral dopamine","volume":"24","author":"Moore","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib178","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI83844","article-title":"Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice","volume":"126","author":"Fritz","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2026.102518_bib179","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/jnr.21425","article-title":"PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity","volume":"85","author":"Carrasco","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrendo.2010.194","article-title":"Stress responses: the contribution of prostaglandin E(2) and its receptors","volume":"7","author":"Furuyashiki","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbrep.2026.102518_bib181","doi-asserted-by":"crossref","first-page":"16066","DOI":"10.1073\/pnas.0504908102","article-title":"Prostaglandin E receptor EP1 controls impulsive behavior under stress","volume":"102","author":"Matsuoka","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrep.2026.102518_bib182","doi-asserted-by":"crossref","first-page":"8611","DOI":"10.1074\/jbc.M710137200","article-title":"Two distinct pathways for Cyclooxygenase-2 protein degradation","volume":"283","author":"Mbonye","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102518_bib183","doi-asserted-by":"crossref","first-page":"7565","DOI":"10.1007\/s00253-018-9155-6","article-title":"Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1","volume":"102","author":"Chen","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbrep.2026.102518_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105969","article-title":"Glucagon-like peptide-1 receptor agonist exendin-4 mitigates lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages","volume":"77","author":"Lu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib185","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.86","article-title":"Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels","volume":"6","author":"Reddy","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbrep.2026.102518_bib186","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2174\/1570159X20666211223130228","article-title":"Biomedical perspectives of acute and chronic neurological and neuropsychiatric sequelae of COVID-19","volume":"20","author":"Stefano","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib187","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/brainsci3010039","article-title":"Exercise benefits brain function: the monoamine connection","volume":"3","author":"Lin","year":"2013","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib188","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1021\/acs.molpharmaceut.8b00532","article-title":"Meloxicam improves cognitive impairment of diabetic rats through COX2-PGE2-EPs-cAMP\/pPKA pathway","volume":"15","author":"Li","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrep.2026.102518_bib189","doi-asserted-by":"crossref","DOI":"10.1080\/24740527.2023.2217865","article-title":"Understanding the experience and impacts of Brain fog in chronic pain: a scoping review","volume":"7","author":"Dass","year":"2023","journal-title":"Can J Pain"},{"key":"10.1016\/j.bbrep.2026.102518_bib190","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1248\/bpb.34.1170","article-title":"Prostaglandin E2 and pain--an update","volume":"34","author":"Kawabata","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrep.2026.102518_bib191","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4168\/aair.2021.13.6.882","article-title":"Activation of dopamine D2 receptor alleviates neuroinflammation in a mouse model of allergic rhinitis with olfactory dysfunction","volume":"13","author":"Liu","year":"2021","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib192","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/00016489.2012.712214","article-title":"Expression of prostanoid receptors (EP1, 2, 3, and 4) in normal and methimazole-treated mouse olfactory epithelium","volume":"133","author":"Fukuiri","year":"2012","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.bbrep.2026.102518_bib193","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1124\/jpet.109.152520","article-title":"Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation","volume":"330","author":"Pekcec","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.bbrep.2026.102518_bib194","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(87)91580-0","article-title":"The involvement of the sympathetic nervous system in the centrogenic pressor and tachycardiac effects of prostaglandins E2 and F2 alpha in anaesthetised cats","volume":"435","author":"Rao","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib195","article-title":"Significant increase in prostaglandin E-major urinary metabolite with physical exercise suggesting muscle inflammation","volume":"16","author":"Okayasu","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.bbrep.2026.102518_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103358","volume":"86","author":"Hohberger","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.bbrep.2026.102518_bib197","article-title":"Influence on eye displacement in MRI after rovunaptabin (BC007) in Post-COVID syndrome: recover, a cross-over randomized controlled pilot trial","volume":"66","author":"Mardin","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib198","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.754667","article-title":"Case report: neutralization of autoantibodies targeting G-Protein-Coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection","volume":"8","author":"Hohberger","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib161","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/jim-2021-002051","article-title":"Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines","volume":"70","author":"Glynne","year":"2022","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib199","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.4049\/jimmunol.179.11.7899","article-title":"Histamine directly and synergistically with lipopolysaccharide stimulates cyclooxygenase-2 expression and prostaglandin I(2) and E(2) production in human coronary artery endothelial cells","volume":"179","author":"Tan","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2026.102518_bib200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF01518519","article-title":"Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy","volume":"37","author":"Uotila","year":"1993","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbrep.2026.102518_bib201","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11539-0","article-title":"Hyperbaric oxygen therapy for long COVID: a prospective registry","volume":"15","author":"van Berkel","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102518_bib202","doi-asserted-by":"crossref","DOI":"10.3390\/life14040438","article-title":"Effects of hyperbaric oxygen therapy on long COVID: a systematic review","volume":"14","author":"Wu","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.bbrep.2026.102518_bib203","first-page":"85","article-title":"[The relationship between the expression of PGE2 and COX-2 and the osteogenic activity and oxygen level of alveolar bone]","volume":"33","author":"Su","year":"2024","journal-title":"Shang Hai Kou Qiang Yi Xue"},{"key":"10.1016\/j.bbrep.2026.102518_bib204","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejphar.2007.05.056","article-title":"Prevention and suppression of pyrogenic fever in rabbits by hyperbaric oxygen","volume":"570","author":"Niu","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2009.01.013","article-title":"Hyperbaric oxygen causes both antiinflammation and antipyresis in rabbits","volume":"606","author":"Niu","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib206","doi-asserted-by":"crossref","first-page":"93","DOI":"10.22462\/3.4.2017.2","article-title":"Effect of hyperbaric oxygen therapy on blood pressure in patients undergoing treatment","volume":"44","author":"Heyboer Rd","year":"2017","journal-title":"Undersea Hyperb. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103681","article-title":"Effect of subcutaneous lidocaine-hydroxypropyl-\u03b2-cyclodextrin (HP-\u03b2-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study","volume":"90","author":"Oostwouder","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.bbrep.2026.102518_bib208","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2460\/ajvr.70.10.1259","article-title":"Anti-inflammatory effects of intravenously administered lidocaine hydrochloride on ischemia-injured jejunum in horses","volume":"70","author":"Cook","year":"2009","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib209","article-title":"Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19","volume":"36","author":"Isman","year":"2024","journal-title":"Brain Behav Immun Health"},{"key":"10.1016\/j.bbrep.2026.102518_bib210","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232502","article-title":"Low-dose naltrexone as a treatment for chronic fatigue syndrome","volume":"13","author":"Bolton","year":"2020","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.bbrep.2026.102518_bib211","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1021\/acs.jcim.7b00717","article-title":"Dissecting the innate immune recognition of opioid inactive isomer (+)-Naltrexone derived toll-like receptor 4 (TLR4) antagonists","volume":"58","author":"Zhang","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrep.2026.102518_bib212","article-title":"Stellate ganglion block relieves long COVID-19 symptoms in 86% of patients: a retrospective cohort study","volume":"15","author":"Pearson","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bbrep.2026.102518_bib213","doi-asserted-by":"crossref","DOI":"10.3390\/e20100795","article-title":"The interaction analysis between the sympathetic and parasympathetic systems in CHF by using transfer entropy method","volume":"20","author":"Luo","year":"2018","journal-title":"Entropy"},{"key":"10.1016\/j.bbrep.2026.102518_bib214","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.12998\/wjcc.v11.i10.2160","article-title":"Treatment of stellate ganglion block in diseases: its role and application prospect","volume":"11","author":"Deng","year":"2023","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.bbrep.2026.102518_bib215","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1393371","article-title":"Transcutaneous vagus nerve stimulation improves long COVID symptoms in a female cohort: a pilot study","volume":"15","author":"Zheng","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbrep.2026.102518_bib216","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1136\/annrheumdis-2013-203215.7","article-title":"A2.7 effects of vagus nerve stimulation on the central prostaglandin System and substance P following peripheral inflammation","volume":"72","author":"Revathikumar","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bbrep.2026.102518_bib219","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2500\/aap.2022.43.220018","article-title":"Long COVID: a proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome","volume":"43","author":"Buonsenso","year":"2022","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.bbrep.2026.102518_bib220","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00089","article-title":"Prostaglandin E2 as a modulator of viral infections","volume":"8","author":"Sander","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib221","doi-asserted-by":"crossref","DOI":"10.3390\/v13040700","article-title":"Long-COVID and Post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms","volume":"13","author":"Silva Andrade","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bbrep.2026.102518_bib222","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1006\/bbrc.1995.1378","article-title":"Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages","volume":"208","author":"Arias-Negrete","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrep.2026.102518_bib223","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/mol.113.089573","article-title":"Polarization of the innate immune response by prostaglandin E2: a puzzle of receptors and signals","volume":"85","author":"Rodr\u00edguez","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib224","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0165-2478(02)00185-2","article-title":"Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1","volume":"84","author":"Roper","year":"2002","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbrep.2026.102518_bib225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2567.2009.03152.x","article-title":"Inhibition of cyclooxygenase-2 impairs the expression of essential plasma cell transcription factors and human B-lymphocyte differentiation","volume":"129","author":"Bernard","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.bbrep.2026.102518_bib226","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-0043-1776713","article-title":"COVID-19 and Long-COVID thrombosis: from clinical and basic science to therapeutics","volume":"124","author":"Violi","year":"2024","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.bbrep.2026.102518_bib227","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13237124","article-title":"Lights and shadows of long COVID: are latent infections the real hidden enemy?","volume":"13","author":"Serapide","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrep.2026.102518_bib228","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021330","article-title":"The microbiota in long COVID","volume":"25","author":"\u00c1lvarez-Santacruz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib229","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd7954","article-title":"Prostaglandin E(2) promotes intestinal inflammation via inhibiting microbiota-dependent regulatory T cells","volume":"7","author":"Crittenden","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.bbrep.2026.102518_bib230","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1053\/j.gastro.2020.02.022","article-title":"Produced by mast cells in Colon tissues from patients with irritable bowel syndrome, contributes to visceral hypersensitivity in mice","volume":"158","author":"Grabauskas","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrep.2026.102518_bib231","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2022.02.016","article-title":"Mucosal serotonin reuptake transporter expression in irritable bowel syndrome is modulated by Gut microbiota via mast cell\u2013prostaglandin E2","volume":"162","author":"Gao","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrep.2026.102518_bib232","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00024382-200116030-00003","article-title":"PGE2 suppresses intestinal T cell function in thermal injury: a cause of enhanced bacterial translocation","volume":"16","author":"Choudhry","year":"2001","journal-title":"Shock"},{"key":"10.1016\/j.bbrep.2026.102518_bib233","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1007\/s11357-024-01165-5","article-title":"Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches","volume":"46","author":"Molnar","year":"2024","journal-title":"GeroScience"},{"key":"10.1016\/j.bbrep.2026.102518_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2024.102614","article-title":"Prostaglandin E2 affects mitochondrial function in adult mouse cardiomyocytes and hearts","volume":"201","author":"Bryson","year":"2024","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.bbrep.2026.102518_bib235","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-024-07352-w","article-title":"PGE(2) inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function","volume":"629","author":"Morotti","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2026.102518_bib236","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/biom14080965","article-title":"The significance of endothelial dysfunction in long COVID-19 for the possible future pandemic of chronic kidney disease and cardiovascular disease","volume":"14","author":"Yanai","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrep.2026.102518_bib237","first-page":"3967","article-title":"COX-2 mediates PM2.5-induced apoptosis and inflammation in vascular endothelial cells","volume":"9","author":"Yin","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib238","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68019-w","article-title":"Prostaglandin E2 breaks down pericyte-endothelial cell interaction via EP1 and EP4-dependent downregulation of pericyte N-cadherin, connexin-43, and R-Ras","volume":"10","author":"Perrot","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2026.102518_bib239","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2025.111570","article-title":"Calcitonin gene-related peptide-induced central sensitization: a hypothesis for long COVID symptoms","volume":"195","author":"Lee","year":"2025","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bbrep.2026.102518_bib240","doi-asserted-by":"crossref","DOI":"10.1186\/s13018-016-0460-4","article-title":"Activation of calcitonin gene-related peptide signaling through the prostaglandin E2-EP1\/EP2\/EP4 receptor pathway in synovium of knee osteoarthritis patients","volume":"11","author":"Minatani","year":"2016","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bbrep.2026.102518_bib241","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1471-4159.2010.06927.x","article-title":"Chronic prostaglandin E2 treatment induces the synthesis of the pain-related peptide substance P and calcitonin gene-related peptide in cultured sensory ganglion explants","volume":"115","author":"Ma","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrep.2026.102518_bib242","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/2211-5463.13027","article-title":"miR-34a-5p up-regulates the IL-1\u03b2\/COX2\/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons","volume":"11","author":"Zhang","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.bbrep.2026.102518_bib243","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2023.09.013","article-title":"Serotonin reduction in post-acute sequelae of viral infection","volume":"186","author":"Wong","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbrep.2026.102518_bib244","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0306-4522(01)00027-6","article-title":"Prostaglandin EP3 receptor protein in serotonin and catecholamine cell groups: a double immunofluorescence study in the rat brain","volume":"103","author":"Nakamura","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbrep.2026.102518_bib245","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41569-023-00962-3","article-title":"Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a major health-care burden","volume":"21","author":"Fedorowski","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib246","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/sj.bjp.0701720","article-title":"Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype","volume":"123","author":"Spicuzza","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102518_bib247","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(02)00174-X","article-title":"Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats","volume":"324","author":"Ariumi","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrep.2026.102518_bib217","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.5114\/aoms\/135703","article-title":"Bioactive lipid-based therapeutic approach to COVID-19 and other similar infections","volume":"19","author":"Das","year":"2023","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbrep.2026.102518_bib218","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drudis.2016.08.003","article-title":"Structural features of subtype-selective EP receptor modulators","volume":"22","author":"Markovi\u010d","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbrep.2026.102518_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.922422","article-title":"Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome","volume":"12","author":"Queiroz","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbrep.2026.102518_bib160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijid.2021.06.017","article-title":"Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from may to August 2020","volume":"109","author":"Kaspersen","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbrep.2026.102518_bib162","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1523\/JNEUROSCI.2887-19.2020","article-title":"EP3R-Expressing glutamatergic preoptic neurons mediate inflammatory fever","volume":"40","author":"Machado","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrep.2026.102518_bib163","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/01.ATV.0000177814.41505.41","article-title":"Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human","volume":"25","author":"Cipollone","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrep.2026.102518_bib164","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prostaglandins.2015.10.001","article-title":"The receptor EP3 to PGE2: a rational target to prevent atherothrombosis without inducing bleeding","volume":"121","author":"Mawhin","year":"2015","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.bbrep.2026.102518_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108265","article-title":"Prostaglandin E(2)-EP4 axis promotes lipolysis and fibrosis in adipose tissue leading to ectopic fat deposition and insulin resistance","volume":"33","author":"Inazumi","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrep.2026.102518_bib166","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1248\/bpb.b22-00270","article-title":"Metabolic regulation in adipocytes by prostanoid receptors","volume":"45","author":"Inazumi","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrep.2026.102518_bib167","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2337\/db12-0769","article-title":"Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates Glucose- and hormone-stimulated insulin secretion","volume":"62","author":"Kimple","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrep.2026.102518_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101347","article-title":"Pharmacological blockade of the EP3 prostaglandin E(2) receptor in the setting of type 2 diabetes enhances \u03b2-cell proliferation and identity and relieves oxidative damage","volume":"54","author":"Bosma","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.bbrep.2026.102518_bib169","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1432-1033.1993.tb18468.x","article-title":"Glycogenolytic and antiglycogenolytic prostaglandin E2 actions in rat hepatocytes are mediated via different signalling pathways","volume":"218","author":"P\u00fcschel","year":"1993","journal-title":"Eur. J. Biochem."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:39:47Z","timestamp":1781739587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":247,"alternative-id":["S2405580826000786"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102518","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent prostaglandin E2 upregulation and hormonal multi-resistance: A hypothesis for long COVID","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102518"}}